1mr9

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1mr9.gif|left|200px]]<br /><applet load="1mr9" size="350" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1mr9.gif|left|200px]]
-
caption="1mr9, resolution 3.00&Aring;" />
+
 
-
'''Crystal structure of Streptogramin A Acetyltransferase with acetyl-CoA bound'''<br />
+
{{Structure
 +
|PDB= 1mr9 |SIZE=350|CAPTION= <scene name='initialview01'>1mr9</scene>, resolution 3.00&Aring;
 +
|SITE=
 +
|LIGAND= <scene name='pdbligand=ACO:ACETYL COENZYME *A'>ACO</scene>
 +
|ACTIVITY=
 +
|GENE=
 +
}}
 +
 
 +
'''Crystal structure of Streptogramin A Acetyltransferase with acetyl-CoA bound'''
 +
 
==Overview==
==Overview==
Line 7: Line 16:
==About this Structure==
==About this Structure==
-
1MR9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Enterococcus_faecium Enterococcus faecium] with <scene name='pdbligand=ACO:'>ACO</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MR9 OCA].
+
1MR9 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Enterococcus_faecium Enterococcus faecium]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MR9 OCA].
==Reference==
==Reference==
-
Structural basis of Synercid (quinupristin-dalfopristin) resistance in Gram-positive bacterial pathogens., Kehoe LE, Snidwongse J, Courvalin P, Rafferty JB, Murray IA, J Biol Chem. 2003 Aug 8;278(32):29963-70. Epub 2003 May 27. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=12771141 12771141]
+
Structural basis of Synercid (quinupristin-dalfopristin) resistance in Gram-positive bacterial pathogens., Kehoe LE, Snidwongse J, Courvalin P, Rafferty JB, Murray IA, J Biol Chem. 2003 Aug 8;278(32):29963-70. Epub 2003 May 27. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/12771141 12771141]
[[Category: Enterococcus faecium]]
[[Category: Enterococcus faecium]]
[[Category: Single protein]]
[[Category: Single protein]]
Line 21: Line 30:
[[Category: left-handed parallel-beta helix domain]]
[[Category: left-handed parallel-beta helix domain]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:58:15 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 12:47:18 2008''

Revision as of 10:47, 20 March 2008


PDB ID 1mr9

Drag the structure with the mouse to rotate
, resolution 3.00Å
Ligands:
Coordinates: save as pdb, mmCIF, xml



Crystal structure of Streptogramin A Acetyltransferase with acetyl-CoA bound


Overview

Synercid, a new semisynthetic streptogramin-derived antibiotic containing dalfopristin and quinupristin, is used in treatment of life-threatening infections caused by glycopeptide-resistant Enterococcus faecium and other bacterial pathogens. However, dissemination of genes encoding virginiamycin acetyltransferases, enzymes that confer resistance to streptogramins, threatens to limit the medical utility of the quinupristin-dalfopristin combination. Here we present structures of virginiamycin acetyltransferase D (VatD) determined at 1.8 A resolution in the absence of ligands, at 2.8 A resolution bound to dalfopristin, and at 3.0 A resolution in the presence of acetyl-coenzyme A. Dalfopristin is bound by VatD in a similar conformation to that described previously for the streptogramin virginiamycin M1. However, specific interactions with the substrate are altered as a consequence of a conformational change in the pyrollidine ring that is propagated to adjacent constituents of the dalfopristin macrocycle. Inactivation of dalfopristin involves acetyl transfer from acetyl-coenzyme A to the sole (O-18) hydroxy group of the antibiotic that lies close to the side chain of the strictly conserved residue, His-82. Replacement of residue 82 by alanine is accompanied by a fall in specific activity of >105-fold, indicating that the imidazole moiety of His-82 is a major determinant of catalytic rate enhancement by VatD. The structure of the VatD-dalfopristin complex can be used to predict positions where further structural modification of the drug might preclude enzyme binding and thereby circumvent Synercid resistance.

About this Structure

1MR9 is a Single protein structure of sequence from Enterococcus faecium. Full crystallographic information is available from OCA.

Reference

Structural basis of Synercid (quinupristin-dalfopristin) resistance in Gram-positive bacterial pathogens., Kehoe LE, Snidwongse J, Courvalin P, Rafferty JB, Murray IA, J Biol Chem. 2003 Aug 8;278(32):29963-70. Epub 2003 May 27. PMID:12771141

Page seeded by OCA on Thu Mar 20 12:47:18 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools